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he effect of Aloe vera on the reduction of plaque and gingivitis was evaluated in a randomized, parallel and double-blind
clinical trial. Subjects were randomly allocated to the test group (n=15) – dentifrice containing Aloe vera - or the control group
(n=15) – fluoridated dentifrice. Plaque index (PI) and gingival bleeding index (GBI) were assessed at days 0 and 30. Subjects
were asked to brush their teeth with the control or test dentifrice, three times a day, during a 30-day period. There was a
significant reduction on plaque and gingivitis in both groups, but no statistically significant difference was observed among
them (p>0.01). The dentifrice containing Aloe vera did not show any additional effect on plaque and gingivitis control
compared to the fluoridated dentifrice.
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INTRODUCTION
Plaque-induced gingivitis is one of the most frequent
periodontal diseases, affecting more than 90% of the
population, regardless of age, sex or race20. Brazilian
epidemiologic studies show a high prevalence of gingival
inflammation, ranging from 74% to 100%, although the mean
individual percentage of gingival bleeding varies from 28%
to 35%5.
Mechanical plaque control is the most effective method
of controlling plaque and gingivitis2,8. However, the inability
of the normal adult population to perform adequate
toothbrushing has led to the search for chemotherapeutic
agents in order to improve plaque control12. These chemicals,
mainly triclosan and chlorhexidine, have been used as
mouthrinses or added to dentifrices to avoid plaque
formation and development of gingivitis10,12,14,22. As some
of these substances may have undesirable side effects, such
as tooth staining and taste alteration, phytotherapic agents
with antimicrobial and antiinflammatory properties have been
investigated7,16,17.
The use of natural products in the prevention and
treatment of oral conditions has increased recently and could
be of benefit to low-socioeconomic level urban and rural
communities4. Among the various currently available herbal
agents, Aloe vera, popularly known as “babosa”, is a plant
commonly found the Northeast of Brazil. Its foliage, extract
and resin present antimicrobial, antiinflammatory and
healing properties and are indicated to hepatic and stomach
diseases9.
The antimicrobial effect of a dentifrice containing Aloe
vera has been demonstrated in an in vitro study, in which
this phytotherapic agent inhibited the growth of diverse
oral microorganisms, such as S. mutans, S. sanguis, A.
viscosus and C. albicans7. The only study available
evaluating the clinical effects of Aloe vera showed a
significant reduction of gingivitis and plaque accumulation
after use of a mouthrinse containing this natural product20.
To the present date, there is no reported controlled trial
evaluating the efficacy of a dentifrice containing Aloe vera
in the control of plaque and gingivitis. Therefore, the purpose
of the present study was to assess the antiplaque and
antigingivitis effects of this phytotherapic agent compared
to a fluoridated dentifrice.
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MATERIAL AND METHODS
Thirty adult subjects from the University of Fortaleza,
Brazil (15 male and 15 female, aged 35 to 43 years) were
enrolled in this double-blind, parallel, controlled clinical trial.
All randomly screened participants were informed about
the nature of the study and signed an informed consent
form in compliance with the guidelines of the Brazilian
National Health Council. The protocol was approved by the
institutional Ethics Committee (Report Coética/Unifor: 407/
2006).
The subjects were entered in the study if they had
gingival bleeding index (GBI)1 >40%, presence of at least 20
natural teeth and absence of supragingival calculus and
other plaque retentive factors. Subjects with medical
disorders or probing depth >3 mm, individuals under
antimicrobial therapy at least 1 month prior to the study and
using mouthrinses or dentifrices containing substances with
antiinflammatory properties, as well as smokers and
pregnant women were excluded from the trial.
The participants were assigned to either the test group
(n=15) or the control group (n=15) by random permutation
of three.  The test group used a herbal dentifrice containing
Aloe vera (Forever Bright®, Forever Living Products, Tempe,
AZ, USA) and the control group used a fluoridated dentifrice
(Sorriso Dentes Brancos®, Kolynos do Brasil, São Paulo,
SP, Brazil), with no antiinflammatory properties, but with
color and taste similar to those of the test dentifrice.
The volunteers were examined for plaque and gingivitis
at baseline and after 30 days. A single, previously calibrated
examiner3 scored the gingival bleeding index (GBI)1and the
plaque index (PI)19, which were recorded on the buccal,
mesial, distal and lingual surfaces of all teeth. The values of
4 sites of each tooth were averaged to determine the GBI
and PI for each subject. In addition to this examination, the
hard and soft oral tissues were visually inspected for the
presence of any adverse reaction by the same examiner.
After the initial examination, all teeth of each subject
were polished with pumice and flossed to eliminate plaque
remnants. A personal “kit” containing a new toothbrush
(Leader®; Facilit Odontológica e Perfumaria Ltda, Rio de
Janeiro, RJ, Brazil) and the test or control dentifrice was
given to all participants. They were instructed to brush their
teeth for 1 min, three times a day, using the Bass technique,
and to refrain from any other oral hygiene procedures
throughout the period of the clinical trial. Verbal and written
instructions about the correct use of dentifrice were given
to all subjects as well. The tubes containing the dentifrices
were previously coded to warrant that neither the examiner
nor the volunteers knew their content, which was revealed
only after completion of the study. The subjects were asked
to return their dentifrice tubes, that were weighted by a digital
balance (Filizola, modelo BP6, Indústrias Filizola S.A., São
Paulo, SP, Brazil), previously and after the trial, so that
compliance could be indirectly evaluated.
Student’s t-test was used to evaluate statistical
differences between the weights of dentifrice tubes on days
0 and 30 ( α=0.01). Mann-Whitney test was performed to
evaluate statistical differences between control and test
groups on days 0 and 30 (α=0.01). In each group, the mean
scores of GBI and PI were compared between baseline and
the end of the trial by the Wilcoxon test (α=0.01). Results
are presented as mean and standard deviation.
RESULTS
The test dentifrice had a good acceptance and did not
show adverse effects, such as formation of abscess and
ulcerations or allergic reactions. Only one subject in the test
group reported unpleasant taste, but he did not drop out
the clinical trial.
There was a significant reduction of dentifrice tube
weights between days 0 and 30 in both groups (p<0.001),
which indirectly indicated that the volunteers actually used
the dentifrices (Table 1).
On day 0, there was no statistically significant difference
between the control and test groups with respect to GBI
  Control Test
Day 0 Number 15 15
Mean 88.8 128.4
Standard deviation 1.2 1.6
Day 30 Number 15 15
Mean 32.33 71.43
Standard deviation 8.77 21.97
p <0.001 <0.001
TABLE 1- Weights of dentifrice tubes (in g) means and
standard deviation for the control and test groups
Control Test p
Day 0 Number 15 15
Mean 0.59 0.57 0.8774
Standard deviation 0.12 0.01
Day 30 Number 15 15
Mean 0.26 0.27 0.9346
Standard deviation 0.01 0.004
p 0.002 0.001
TABLE 2- Gingival Bleeding Index (GBI) means and standard deviation on day 0 and day 30 for the control and test groups
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(p=0.8774) and PI (p=0.0477) means. These results indicated
that both groups were well balanced at baseline (Tables 2
and 3). At the 30th day, plaque (p=0.2801) and gingival
bleeding (p=0.9346) were present in both groups, but the
difference between them was not significant statistically
(Tables 2 and 3).
Comparing the means between baseline and day 30 in
each group, there was statistically significant difference in
both the GBI (p=0.002, control group and p=0.001, test group)
and PI indexes (p=0.002, control group and p=0.001, test
group) (Tables 2 and 3).
DISCUSSION
Aloe vera is a natural product contained in herbal
dentifrices with commercial appeal on the control of plaque
and gingivitis. Despite its free commercial use, this
phytotherapic agent does not have sufficient data to support
its antigingivitis and antiplaque claims21.
To the best of our knowledge, the present study is the
first report about effect of a dentifrice containing Aloe vera
on gingivitis. The results showed that both toothpastes
were efficient on plaque reduction (23% in test group and
19% in control group). This percent difference was not
significant at the end of the trial. In spite of a reported in
vitro inhibitory effect of Aloe vera against microorganisms
from supragingival biofilm7, its in vivo antiplaque effect in
the present study was not satisfactory. It is interesting to
note that this previous study7 evaluated a dentifrice that
also contained other antiplaque agents, which probably
masked the effect of Aloe vera.
The test and control dentifrices reduced gingivitis
significantly, although the fluoridated dentifrice presented
a higher percent reduction on bleeding areas (56% versus
53%). The GBI is a generally used dichotomous index to
evaluate gingivitis, but it does not access the severity of
gingival inflammation. Studies evaluating the reduction of
gingivitis by a grading index could be interesting to
complement these results. Gingival index uses a scale in
which color changes in the gingival tissues precede bleeding
on probing; however this parameter is not necessarily an
accurate indicator of gingivitis18.
The findings of the present study are in agreement with
those of Villalobos, et al.20 (2001), who observed a significant
reduction on plaque and gingivitis after a 30-day use of
mouthrinses containing Aloe vera associated to
toothbrushing. This study20 also showed an additional
antiplaque and antigingivitis effect of this phytotherapic
agent, which was not observed in the present clinical trial.
Villalobos, et al.20 (2001) used a higher concentration of
Aloe vera (50%), which could explain the better effect of
this phytotherapic agent when compared to our findings.
Although the manufacturer does not inform the
concentration of Aloe vera in the product used in the present
study, the percentage of therapeutic agent in a dentifrice
usually range from 0.4% to 1.0% of the total formulation6,
which was probably the concentration used in our study
and could explain those results. Furthermore, Villalobos, et
al.20 (2001) used a mouthrinse containing only Aloe vera as
the active agent, favoring its action without interference of
other components. The test dentifrice used on the present
trial contains other agents that can promote a moderate
antiplaque effect, such as menthol and sodium lauryl
sulfate12,21. Since the last two components are also present
in the control dentifrice and considering that no difference
was found between groups, one can conclude that the herbal
agent had no influence on the results. The antagonism of
diverse substances with similar effects, in the same product,
should be considered as well. This fact has been highlighted
by Wua and Savitt21 (2002) and confirmed by other clinical
trials comparing fluoridated and herbal dentifrices11,15.
Home-use dentifrice studies are often influenced by a
number of factors which can mask the superiority of a test
agent over the controls. Participants in clinical trials may
experience some improvement associated not specifically
to the therapeutic properties of the test agent but rather
related to a behavior change - Hawthorne effect15. Subjects
enrolled in oral hygiene studies usually improve their
toothbrushing, irrespective of the product they receive11,13,15.
Although the volunteers of the present study were not
aware of which dentifrice they were using, another important
factor is the Novelty effect, which is the motivation of oral
hygiene practice by the use of a new substance. On the
other hand, lack of compliance in the correct use of dentifrice
can occur as well15. In order to minimize its occurrence, the
participants were asked to bring the dentifrice tubes at the
end of the trial to be weighed, so we could evaluate indirectly
subject compliance. The significant difference between
weights in both groups, before and after the study, indicates
Control Test p
Day 0 Number 15 15
Mean 3.27 3.58 0.0477
Standard deviation 0.55 0.36
Day 30 Number 15 15
Mean 2.65 2.78 0.2801
Standard deviation 0.51 0.39
p 0.002 0.001
TABLE 3- Plaque index (PI) means and standard deviation on day 0 and day 30 for the control and test groups
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that the participants used the products, but does not confirm
if they were used correctly. Compliance was also reinforced
by reduction on gingivitis in both groups.
The experimental period of 30 days was chosen for
permitting comparison to other studies. However, it may
not be sufficient to show the superiority of the test dentifrice
over the control toothpaste15. Further long-term studies must
be performed to evaluate the antigingivitis effect of this
herbal dentifrice. If its real benefit is confirmed, the use of
Aloe vera should be advantageous in cases where patients
have little motor skills and toothbrushing is compromised.
CONCLUSION
Within the limits of this clinical study, it may be concluded
that the dentifrice containing Aloe vera did not show any
additional effect on plaque and gingivitis control compared
to the fluoridated dentifrice.
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